Title: Actinium Pharmaceuticals - Development of Therapeutics Utilizing Bismuth 213 and Actinium 225
Description: Since its establishment in 1993, Newark, NJ based Actinium Pharmaceuticals,Inc. has been focused on the development of therapeutics utilizing bismuth 213 and actinium 225.
Keywords:
research,
bismuth 213,
actinium 225,
alpha particle immunotherapy,
cancer treatment,
leukemia treatment,
therapeutics,
isotope,
immunotherapies,
monoclonal antibodies,
radioisotopes,
antibody,
actinium pharmaceuticals